Blog

January 4, 2023

Using the EHR Workflow to Raise Awareness of New Medical Device Brand

OptimizeRx

Using the EHR Workflow to Raise Awareness of New Medical Device Brand According to the CDC, over 37 million people in the US suffer from diabetes, and recent research from the Johns Hopkins Bloomberg School of Public Health suggests that...

December 12, 2022

HCP Engagement and the Sales Rep: Enabling Face-to-Face Connections

OptimizeRx

HCP Engagement in the Digital Marketing Era Sales representatives have long been a vital ingredient in life science companies' HCP engagement strategies – educating physicians about product/device benefits, clinical results,...

November 18, 2022

HCP Engagement in the EHR: Strategies for Medical Device Marketing

OptimizeRx

The Digital Point of Care: New Opportunities for Medical Device Marketing It’s a scenario we’ve all been in: you have a doctor’s appointment about a new or worsening symptom. Often, the first thing you’ll do is fill out a patient intake...

November 10, 2022

Expanding Account-Based Marketing with Omnichannel HCP Engagement

OptimizeRx

Account-Based Marketing in Healthcare Account-based marketing (ABM) continues to be an attractive solution for Life Science brands looking to gain traction and share-of-voice within key hospital systems – and the HCPs making patient care...

November 7, 2022

Aligning Your Digital Marketing Strategy with the Patient Journey

OptimizeRx

As medtech and medical device companies continue to advance their digital strategies, understanding and aligning with the digital patient journey have become more important than ever. But how can your device brand most effectively support...

August 30, 2022

Increased Osteoarthritis Brand Awareness and Prescribing Through Copay Promotion

OptimizeRx

There are more than 100 different types of arthritis, but osteoarthritis (OA) is the most common—impacting 32.5 Million US adults and creating an overall economic burden of almost $140 Billion annually.

August 9, 2022

Addressing Medication Affordability in Vulnerable Patients During COVID-19

OptimizeRx

Pre-existing condition. This is a term we heard thrown around a lot at the start of 2020. It’s still a part of our day-to-day vocabulary, especially if you're one of the estimated 40% of Americans living with a medical-related ailment that...

July 28, 2022

What’s Your Market Access Digital Maturity?

OptimizeRx

When pharma brands become fully digitally enabled, market access pathways are optimized and providers have the tools they need to begin patients on your therapy rapidly and easily. Formulary awareness, patient enrollment, and onboarding,...

July 26, 2022

Improving Access to Mental Healthcare with OptimizeRx Financial Messaging

OptimizeRx

The 2022 State of Mental Health in America report highlights that 24.7% of adults with a mental illness in 2019 reported an unmet need for treatment—this number has seen a steady increase every year since 2011.

June 2, 2022

Making the Case for a Digital Revolution in Market Access

OptimizeRx

As pharmaceutical companies evolve toward digital-first commercial models, U.S. market access strategies seem to be lagging in the digital revolution. Companies face many different hurdles to adapting their market access strategies for a...

May 26, 2022

Predict Patient Adherence Threats to Help HCPs Keep Patients on Course

OptimizeRx

Non-adherence to prescribed therapy can create extraordinary risks for patients. Even when provided with correct diagnoses and effective treatment plans, patients can often fail to take their medication as directed for a variety of ...

May 17, 2022

Inefficient Access Pathways Cost More Than Just HCP Time and Effort

OptimizeRx

There may be no greater threat to patient outcomes than the current barriers to therapy access—especially for specialty medications.